vs

Side-by-side financial comparison of Roivant Sciences Ltd. (ROIV) and Glimpse Group, Inc. (VRAR). Click either name above to swap in a different company.

Roivant Sciences Ltd. is the larger business by last-quarter revenue ($2.0M vs $1.3M, roughly 1.5× Glimpse Group, Inc.). Glimpse Group, Inc. runs the higher net margin — -94.3% vs -13301.2%, a 13206.9% gap on every dollar of revenue. On growth, Glimpse Group, Inc. posted the faster year-over-year revenue change (-59.0% vs -77.8%). Glimpse Group, Inc. produced more free cash flow last quarter ($-747.3K vs $-201.4M).

Roivant Sciences Ltd. is an American multinational healthcare company focused on applying technology to drug development and building subsidiary life sciences and health technology companies. It was founded in 2014 by Vivek Ramaswamy and is currently headed by CEO Matt Gline. Roivant maintains its headquarters in New York City as well as major offices in the biotech hubs of Boston and Basel.

The Glimpse Group, Inc. is a specialized immersive technology firm focused on developing virtual reality (VR) and augmented reality (AR) solutions. It serves enterprise, education, healthcare, and entertainment segments, offering custom immersive experiences and software tools for clients across North America and select global markets.

ROIV vs VRAR — Head-to-Head

Bigger by revenue
ROIV
ROIV
1.5× larger
ROIV
$2.0M
$1.3M
VRAR
Growing faster (revenue YoY)
VRAR
VRAR
+18.8% gap
VRAR
-59.0%
-77.8%
ROIV
Higher net margin
VRAR
VRAR
13206.9% more per $
VRAR
-94.3%
-13301.2%
ROIV
More free cash flow
VRAR
VRAR
$200.7M more FCF
VRAR
$-747.3K
$-201.4M
ROIV

Income Statement — Q3 FY2026 vs Q2 FY2026

Metric
ROIV
ROIV
VRAR
VRAR
Revenue
$2.0M
$1.3M
Net Profit
$-265.9M
$-1.2M
Gross Margin
60.7%
Operating Margin
-16966.1%
-97.1%
Net Margin
-13301.2%
-94.3%
Revenue YoY
-77.8%
-59.0%
Net Profit YoY
-257.0%
-4837.1%
EPS (diluted)
$-0.38
$-0.06

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ROIV
ROIV
VRAR
VRAR
Q4 25
$2.0M
$1.3M
Q3 25
$1.6M
$1.4M
Q2 25
$2.2M
Q1 25
$-39.6M
Q4 24
$9.0M
Q3 24
$4.5M
Q2 24
$8.0M
Q1 24
$28.9M
Net Profit
ROIV
ROIV
VRAR
VRAR
Q4 25
$-265.9M
$-1.2M
Q3 25
$-113.5M
$-1.0M
Q2 25
$-223.4M
Q1 25
$-206.5M
Q4 24
$169.4M
Q3 24
$-230.2M
Q2 24
$95.3M
Q1 24
$-151.1M
Gross Margin
ROIV
ROIV
VRAR
VRAR
Q4 25
60.7%
Q3 25
72.1%
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Operating Margin
ROIV
ROIV
VRAR
VRAR
Q4 25
-16966.1%
-97.1%
Q3 25
-19492.9%
-95.6%
Q2 25
-13130.0%
Q1 25
674.8%
Q4 24
-3042.6%
Q3 24
-7636.0%
Q2 24
-1279.5%
Q1 24
-919.5%
Net Margin
ROIV
ROIV
VRAR
VRAR
Q4 25
-13301.2%
-94.3%
Q3 25
-7225.9%
-73.9%
Q2 25
-10292.9%
Q1 25
521.8%
Q4 24
1878.3%
Q3 24
-5143.8%
Q2 24
1192.7%
Q1 24
-522.3%
EPS (diluted)
ROIV
ROIV
VRAR
VRAR
Q4 25
$-0.38
$-0.06
Q3 25
$-0.17
$-0.05
Q2 25
$-0.33
Q1 25
$-0.28
Q4 24
$0.23
Q3 24
$-0.31
Q2 24
$0.12
Q1 24
$-0.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ROIV
ROIV
VRAR
VRAR
Cash + ST InvestmentsLiquidity on hand
$4.5B
$3.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$4.3B
$15.3M
Total Assets
$5.2B
$16.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ROIV
ROIV
VRAR
VRAR
Q4 25
$4.5B
$3.3M
Q3 25
$4.4B
$5.6M
Q2 25
$4.5B
Q1 25
$4.9B
Q4 24
$5.1B
Q3 24
$5.4B
Q2 24
$5.7B
Q1 24
$6.5B
Total Debt
ROIV
ROIV
VRAR
VRAR
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
$311.7M
Q1 24
$430.6M
Stockholders' Equity
ROIV
ROIV
VRAR
VRAR
Q4 25
$4.3B
$15.3M
Q3 25
$4.4B
$16.2M
Q2 25
$4.3B
Q1 25
$4.7B
Q4 24
$5.2B
Q3 24
$5.2B
Q2 24
$5.4B
Q1 24
$6.0B
Total Assets
ROIV
ROIV
VRAR
VRAR
Q4 25
$5.2B
$16.0M
Q3 25
$5.1B
$18.3M
Q2 25
$5.0B
Q1 25
$5.4B
Q4 24
$5.8B
Q3 24
$6.2B
Q2 24
$6.5B
Q1 24
$7.2B
Debt / Equity
ROIV
ROIV
VRAR
VRAR
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
0.06×
Q1 24
0.07×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ROIV
ROIV
VRAR
VRAR
Operating Cash FlowLast quarter
$-196.5M
$-739.2K
Free Cash FlowOCF − Capex
$-201.4M
$-747.3K
FCF MarginFCF / Revenue
-10076.0%
-57.5%
Capex IntensityCapex / Revenue
246.9%
0.6%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-776.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ROIV
ROIV
VRAR
VRAR
Q4 25
$-196.5M
$-739.2K
Q3 25
$-185.7M
$-1.3M
Q2 25
$-204.4M
Q1 25
$-172.6M
Q4 24
$-207.3M
Q3 24
$-266.8M
Q2 24
$-192.8M
Q1 24
$-108.5M
Free Cash Flow
ROIV
ROIV
VRAR
VRAR
Q4 25
$-201.4M
$-747.3K
Q3 25
$-193.5M
$-1.3M
Q2 25
$-208.4M
Q1 25
$-173.4M
Q4 24
$-209.1M
Q3 24
$-267.8M
Q2 24
$-193.8M
Q1 24
$-108.8M
FCF Margin
ROIV
ROIV
VRAR
VRAR
Q4 25
-10076.0%
-57.5%
Q3 25
-12317.8%
-92.8%
Q2 25
-9604.5%
Q1 25
438.1%
Q4 24
-2318.5%
Q3 24
-5984.4%
Q2 24
-2425.5%
Q1 24
-376.1%
Capex Intensity
ROIV
ROIV
VRAR
VRAR
Q4 25
246.9%
0.6%
Q3 25
499.6%
0.6%
Q2 25
185.9%
Q1 25
-2.0%
Q4 24
20.3%
Q3 24
22.3%
Q2 24
12.1%
Q1 24
1.2%
Cash Conversion
ROIV
ROIV
VRAR
VRAR
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
-1.22×
Q3 24
Q2 24
-2.02×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ROIV
ROIV

Segment breakdown not available.

VRAR
VRAR

Software Services$1.2M90%
Other$124.4K10%

Related Comparisons